NCT00695604
Withdrawn
Phase 2
Repeated High-dose Inhaled Corticosteroids for Asthma
Overview
- Phase
- Phase 2
- Intervention
- Placebo
- Conditions
- Asthma
- Sponsor
- University of Chicago
- Locations
- 1
- Primary Endpoint
- Airflow inflammation.
- Status
- Withdrawn
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this study is to to compare the effects of high-dose Inhaled Corticosteroids (ICS) vs. placebo in adults with chronic stable asthma.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Arms & Interventions
1
Placebo Comparator All patients assigned to this group will receive: 1. Placebo via Metered Dose Inhaler (MDI). 2. Albuterol via MDI.
Intervention: Placebo
2
Active Comparator All patients assigned to this group will receive: 1. Fluticasone via MDI. 2. Albuterol via MDI.
Intervention: Fluticasone
Outcomes
Primary Outcomes
Airflow inflammation.
Time Frame: Pre-study and post-study drug administration
Secondary Outcomes
- Airflow obstruction.(Pre-study and post-study drug administration)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Evaluation of Inhaled Treatment in SinusitisSinusitisNCT01907204Cliniques universitaires Saint-Luc- Université Catholique de Louvain50
Terminated
Not Applicable
Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at HomeAsthmaNCT01783132Orion Corporation, Orion Pharma142
Completed
Not Applicable
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)AsthmaLung DiseasesNCT00319488National Heart, Lung, and Blood Institute (NHLBI)238
Recruiting
Phase 2
Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPDChronic Obstructive Pulmonary DiseaseNCT05607719University of Miami30
Recruiting
Not Applicable
Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic ChildrenAsthmaNCT03487809National Taiwan University Hospital100